Literature DB >> 17878877

[The impact of large vessel proximity on effectiveness of radiofrequency ablation of hepatocellular carcinoma: a controlled study].

O Seror1, G N'Kontchou, M Muhammad, C Barrucand, M Tin Tin Htar, M Assaban, D Haddar, J C Trinchet, M Beaugrand, N Sellier.   

Abstract

PURPOSE: To evaluate the risk of radiofrequency ablation treatment failure for hepatocellular carcinomas (HCC) next to large vessels.
MATERIALS AND METHODS: Between May 2000 and October 2002, from a total of 83 patients treated by radiofrequency ablation for HCC in a single center, 13 patients with tumor<or=3.5 cm contacting a vessel >or=3 mm in diameter (Group A) were matched with 13 patients with similar size tumors located away from large vessels (Group B). Immediate response and recurrence rate were evaluated on CT.
RESULTS: After mean follow-up interval of 39+/-16.5 months for Group A and 39+/-14 months for Group B, local recurrence rates were 7/12 versus 1/12 respectively (p=0.03). For Group A, 6/7 local recurrences clearly contacted a large vessel.
CONCLUSION: The cooling effect from flowing blood in large vessels markedly increases the rate of local failure of radiofrequency ablation for small HCC located near large vessels.

Entities:  

Mesh:

Year:  2007        PMID: 17878877     DOI: 10.1016/s0221-0363(07)89927-6

Source DB:  PubMed          Journal:  J Radiol        ISSN: 0221-0363


  2 in total

1.  Percutaneous Ablation of Hepatic Tumors at the Hepatocaval Confluence Using Irreversible Electroporation: A Preliminary Study.

Authors:  Tiankuan Li; Wei Huang; Zhiyuan Wu; Yong Wang; Qingbing Wang; Ziyin Wang; Qin Liu; Jingjing Liu; Shenjie Wang; Xiaoyi Ding; Zhongmin Wang
Journal:  Curr Oncol       Date:  2022-05-31       Impact factor: 3.109

2.  Ten-Year Outcomes of Percutaneous Radiofrequency Ablation for Colorectal Cancer Liver Metastases in Perivascular vs. Non-Perivascular Locations: A Propensity-Score Matched Study.

Authors:  Binbin Jiang; Hongjie Luo; Kun Yan; Zhongyi Zhang; Xiaoting Li; Wei Wu; Wei Yang; Minhua Chen
Journal:  Front Oncol       Date:  2020-10-16       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.